Before we even get started today this is going to be post you can share and we honestly hope you do share it. Ok now onto business.
Yesterday Diabetic Investor learned that some Medtronic (NYSE: MDT)sales reps are using material written by Diabetic Investor as sales material. They have done this in two ways via email or printing out past posts and giving them to patients. Not surprisingly the material they are using is about Tandem (NASDAQ: TNDM) and their shaky future. Now before any further let’s get a few things straight;
1. We are not . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.